Nuveen Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.67M | Hold |
157,951
| – | – | ﹤0.01% | 2457 |
|
|
2024
Q3 | $2.29M | Buy |
157,951
+3,517
| +2% | +$51K | ﹤0.01% | 2344 |
|
|
2024
Q2 | $1.31M | Buy |
154,434
+56,839
| +58% | +$484K | ﹤0.01% | 2589 |
|
|
2024
Q1 | $997K | Hold |
97,595
| – | – | ﹤0.01% | 2711 |
|
|
2023
Q4 | $535K | Sell |
97,595
-14,179
| -13% | -$77.7K | ﹤0.01% | 2977 |
|
|
2023
Q3 | $423K | Buy |
111,774
+14,179
| +15% | +$53.6K | ﹤0.01% | 2897 |
|
|
2023
Q2 | $654K | Buy |
+97,595
| New | +$654K | ﹤0.01% | 2833 |
|
|
2022
Q2 | – | Sell |
-64,723
| Closed | -$272K | – | 3386 |
|
|
2022
Q1 | $272K | Buy |
64,723
+1,433
| +2% | +$6.02K | ﹤0.01% | 3139 |
|
|
2021
Q4 | $391K | Sell |
63,290
-12,743
| -17% | -$78.7K | ﹤0.01% | 3128 |
|
|
2021
Q3 | $759K | Buy |
76,033
+20,042
| +36% | +$200K | ﹤0.01% | 3082 |
|
|
2021
Q2 | $1.73M | Buy |
55,991
+5,741
| +11% | +$177K | ﹤0.01% | 2783 |
|
|
2021
Q1 | $2.19M | Buy |
+50,250
| New | +$2.19M | ﹤0.01% | 2576 |
|